We aim to develop new diagnostic techniques and nuclear medical treatments by making the most of cyclotron and PET-MRI.
Responsible for the production of radionuclides and radiopharmaceuticals synthesis useful in medical treatment, and for novel drug research and development.
As a research institution, we endeavor bridge the gaps between developing new diagnostics and therapeutic technologies and elucidating biological functions using cutting-edge imaging and highly accurate measuring equipment in collaboration with the Department of Radiopharmaceuticals Development and Department of Clinical Research and Trial.
Contributing to maintaining and promoting health by conducting medical examinations and performing research using imaging diagnostic equipment.
This department supports, and in some cases conducts, clinical research and clinical trials conducted at our center.
We will analyze the distribution and behaviour of radioactive substances in the environment, assist in an effective decontamination process and provide greater safety and security.